中西経団連会長、リンパ腫再発　入院期間未定、業務「可能な限り行う」

　経団連は２１日、精密検査のため入院中の中西宏明会長（７４）について、リンパ腫の再発が判明したと発表した。引き続き入院しながら治療を行う方針。入院期間は未定だが、中西会長は談話で、「今後の業務については治療スケジュールと体調を考慮しながら、可能な限り行いたい」との意向を表明した。
　既に化学療法による治療を開始。現時点では腫瘍マーカーの数値が好転し、自覚症状や副作用などはないという。
　中西会長は政府の経済財政諮問会議や未来投資会議の民間議員を務めている。こうした会議や経団連の会合には今後、体調や治療状況を見極めた上で、実際に出席するか、リモートで出席するかなどをその都度判断する。経団連は会長代行は置かず、必要に応じて審議員会議長や副会長らが業務を行い、不在をカバーする方針だ。（2020/08/21-18:08）

The Japan Business Federation, or Keidanren, said Friday that its chairman, Hiroaki Nakanishi, has been confirmed to be suffering a relapse in his lymphoma.
   Nakanishi will continue to receive treatment while staying at a hospital. How long he will be hospitalized is undecided.
   Nakanishi, who also serves as a member of the government's Council on Economic and Fiscal Policy and also its Council on Investments for the Future, issued a statement that he hopes to perform his duties as much as allowed by his condition and treatment schedule.
   The Keidanren chief was hospitalized for lymphoma in May 2019 and returned to work in September that year. He was hospitalized again on July 14, after problems were detected in his regular checkups.
   He is currently receiving chemotherapy, showing signs of improvement without suffering side-effects, according to informed sources.